Analytical evaluation of the Bio-Rad Variant II automated HbA1c analyzer

被引:23
作者
Higgins, TN [1 ]
Blakney, GB [1 ]
Dayton, J [1 ]
机构
[1] Dynacare Kasper Med Labs, Edmonton, AB T5V 1B4, Canada
关键词
D O I
10.1016/S0009-9120(01)00229-6
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To evaluate the analytical performance of the Bio-Rad Variant II HbA(IC) analyzer (a completely automated system for the quantification of glycohemoglobin [HbA(IC)] in blood). Design and Methods: The analytical parameters of precision, linearity and analytical range were assessed and HbA(IC) results from the Variant II were compared to HbA(IC) results from the Bio-Rad Variant (a method certified by the National Glycohemoglobin Standardization Program). The effect of a variety of hemoglobin variants on HbA(IC) obtained on the system was investigated. Results: Total imprecision was less than 5% and the results compared well with those from an established method. The method has a wide analytical range with no carryover between specimens. Conclusion: The HbA(IC) method on the Variant II gives acceptable analytical performance. (C) 2001 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:361 / 365
页数:5
相关论文
共 7 条
  • [1] Comparison of hemoglobin A1C results by two different methods on patients with structural hemoglobin variants
    Blakney, GB
    Higgins, TN
    Holmes, DJ
    [J]. CLINICAL BIOCHEMISTRY, 1998, 31 (08) : 619 - 626
  • [2] Bry L, 2001, CLIN CHEM, V47, P153
  • [3] Evaluation of the tosoh HLC-723GHb V A1c 2.2 hemoglobin A1c analyzer
    Chevenne, D
    Marle, N
    Chauffert, M
    Noel, M
    Ducrocq, R
    Trivin, F
    [J]. CLINICAL BIOCHEMISTRY, 1999, 32 (06) : 487 - 490
  • [4] Diabetes control and complication trial research Group (DCCT), 1993, NEW ENGL J MED, V329, P986
  • [5] SIGNIFICANCE OF HIGH HBA1 LEVELS IN NORMAL GLUCOSE-TOLERANCE
    MODAN, M
    MEYTES, D
    ROZEMAN, P
    BENYOSEF, S
    SEHAYEK, E
    BENYOSEF, N
    LUSKY, A
    HALKIN, H
    [J]. DIABETES CARE, 1988, 11 (05) : 422 - 428
  • [6] Economic evaluation of alternative indicators for screening for diabetes mellitus
    Shirasaya, K
    Miyakawa, M
    Yoshida, K
    Takahashi, E
    Shimada, N
    Kondo, T
    [J]. PREVENTIVE MEDICINE, 1999, 29 (02) : 79 - 86
  • [7] 1998, CMAJ S8, V159